{
    "clinical_study": {
        "@rank": "127705", 
        "arm_group": [
            {
                "arm_group_label": "Group 1", 
                "arm_group_type": "Active Comparator", 
                "description": "Group 1 received ablation from distal to ostial of bilateral renal arteries"
            }, 
            {
                "arm_group_label": "Group 2", 
                "arm_group_type": "Experimental", 
                "description": "group 2 received ablation at proximal of bilateral renal arteries"
            }
        ], 
        "brief_summary": {
            "textblock": "Catheter-based renal sympathetic modification has been documented to be effective option for\n      blood pressure control in patients with resistant hypertension, but the safety is still\n      concerned around worldwide. Based on anatomic findings, blocking renal sympathetic nerves at\n      proximity may be enough for successful renal sympathetic modifications. This study was\n      designed to compare the efficacy and safety of full length versus proximal ablation of\n      bilateral renal arteries."
        }, 
        "brief_title": "Full Length Versus Proximal Renal Arteries Ablation", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypertension, Resistant to Conventional Therapy", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "detailed_description": {
            "textblock": "After baseline assessment was completed, patients with resistant hypertension were enrolled,\n      and randomly divided into two groups. This study is going to recruit 40 patients (group 1 VS\n      group 2 = 1:1) with a follow-up duration of one year. Group 1 received ablation from distal\n      to ostial of bilateral renal arteries, group 2 received ablation at proximal of bilateral\n      renal arteries. RDN was performed with saline irrigated catheter. Office and ambulatory\n      blood pressure was measured."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  office systolic blood pressure of 160 mm Hg or more,\n\n          -  patients had to be on a stable drug regimen of at least 3 antihypertensive\n             medications with no changes for 1 month before enrollment.\n\n          -  Despite being treated with at least three antihypertensive drugs(including one\n             diuretic), or confirmed intolerance to medications;\n\n          -  \u2265 18 years old,;\n\n          -  did not have any known secondary cause of hypertension;\n\n          -  had a glomerular filtration rate estimated with the modification of diet in renal\n             disease formula, of 45 ml/min/1.73m2 or more.\n\n        Exclusion Criteria:\n\n          -  patients with type 1 diabetes,\n\n          -  implanted pacemakers or implantable cardioverter defibrillators;\n\n          -  pregnant women;\n\n          -  haemodynamically significant valvular disease;\n\n          -  patients with renovascular abnormalities(including mild to severe renal artery\n             stenosis, especially caused by atherosclerosis, previous renal stenting or\n             angioplasty, or known dual renal arteries, or diameter of renal artery identified by\n             angiography less than 4 mm and/or length of renal artery less than 2 cm)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01848275", 
            "org_study_id": "SWAN- RDN Strategy"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group 1", 
                "description": "The full length RDN was performed discretely from distal to proximal by point to point using Thermocool\u00aeRcatheter", 
                "intervention_name": "Thermocool\u00aeRcatheter", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Group 2", 
                "description": "The proximity renal denervation was performed discretely at 10-15 mm of proximal renal artery, using Thermocool\u00aeRcatheter", 
                "intervention_name": "Thermocool\u00aeRcatheter", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 6, 2013", 
        "location": {
            "contact": {
                "email": "yinyh63@163.com", 
                "last_name": "Yuehui Yin, MD", 
                "phone": "0086-13508335502"
            }, 
            "facility": {
                "address": {
                    "city": "Chongqing", 
                    "country": "China", 
                    "state": "Chongqing", 
                    "zip": "400010"
                }, 
                "name": "2ndChongqingMU"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Clinical Efficacy Comparison of Two Renal Sympathetic Denervation Strategies ---- Full Length Versus Proximal Renal Arteries Ablation", 
        "overall_contact": {
            "email": "yinyh63@163.com", 
            "last_name": "Yuehui Yin, MD", 
            "phone": "0086-13508335502"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee of 2ndChongqingMU", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "office BP and Ambulatory blood pressure", 
            "measure": "Blood pressure", 
            "safety_issue": "Yes", 
            "time_frame": "One year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01848275"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Second Affiliated Hospital of Chongqing Medical University", 
            "investigator_full_name": "Yuehui Yin", 
            "investigator_title": "Director and Professor, Dept. of Cardiology, the second affiliated hospital of Chongqing Medical University, Chongqing Cardiac arrhythmias service center", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "ablation-related complications such as pseudoaneurysm\uff0crenal artery injury", 
            "measure": "ablation-related complications", 
            "safety_issue": "Yes", 
            "time_frame": "One year"
        }, 
        "source": "The Second Affiliated Hospital of Chongqing Medical University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The Second Affiliated Hospital of Chongqing Medical University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}